FDA Adverse Event Injury Summary report: N

PROGEL PLATINUM PLUERAL AIR LEAK SEALANT

MDR report key: 23265962 · Received October 10, 2025

Report

Report Number
1213643-2025-00973
Event Type
Injury
Date Received
October 10, 2025
Date of Event
January 1, 2018
Report Date
September 25, 2025
Manufacturer
NEOMEND INC -2953195
Product Code
NBE
PMA / PMN Number
P010047
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
FR
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

BASED ON THE INFORMATION AVAILABLE, NO CONCLUSIONS CAN BE MADE. THE INFORMATION PROVIDED IN THE ARTICLE INDICATES THAT SOME PATIENTS EXPERIENCED POSTOPERATIVE COMPLICATIONS AND NEEDED HOSPITALIZATION. ADDITIONAL INFORMATION HAS BEEN REQUESTED, BUT CURRENTLY, THE INFORMATION IS LIMITED TO THE CONTENT OF THE ARTICLE. THE ARTICLE DOES NOT REPORT THAT ANY SPECIFIC DEVICE MALFUNCTION OR ALLEGED POST-OP COMPLICATIONS WERE CAUSED OR CONTRIBUTED TO THE USE OF THE PROGEL PLATINUM. REVIEW OF THE INSTRUCTIONS-FOR-USE PROVIDED WITH THE DEVICE, IDENTIFIES PNEUMONIA, EMBOLISM AND PLEURAL EFFUSION AS POSSIBLE ADVERSE REACTIONS AND ARE CONSIDERED FORESEEABLE AND CLINICALLY ACCEPTABLE IN TERMS OF PATIENT BENEFIT. NO LOT NUMBER HAS BEEN PROVIDED; THEREFORE, A REVIEW OF THE MANUFACTURING RECORDS IS NOT POSSIBLE. NOTE, THE DATE OF EVENT (01-JAN-2018) IS CONSIDERED TO BE A BEST ESTIMATE. NOTE: SECTION A THROUGH F - THE INFORMATION PROVIDED BY BD REPRESENTS ALL OF THE KNOWN INFORMATION AT THIS TIME. DESPITE GOOD FAITH EFFORTS TO OBTAIN ADDITIONAL INFORMATION, THE COMPLAINANT / REPORTER WAS UNABLE OR UNWILLING TO PROVIDE ANY FURTHER PATIENT, PRODUCT, OR PROCEDURAL DETAILS TO BD.

Description of Event or Problem · 0

PER JOURNAL ARTICLE: "FEASIBILITY OF VIDEO-ASSISTED THORACOSCOPIC SURGERY AS A REDO CHEST APPROACH FOR LUNG RESECTION IN PATIENTS WITH A HISTORY OF SURGICAL PROCEDURES ON THE SAME SIDE" THE AIM OF THIS STUDY WAS TO REPORT THE RESULTS OF VIDEO-ASSISTED THORACOSCOPIC SURGERY (VATS) AS SURGICAL APPROACH FOR REINTERVENTION AFTER A PREVIOUS IPSILATERAL INTRATHORACIC SURGERY. THIS RETROSPECTIVE MONOCENTRIC OBSERVATIONAL STUDY REQUIRED REVIEW OF MEDICAL FILES OF PATIENTS UNDERGOING MINIMALLY INVASIVE IPSILATERAL REDO SURGERY BETWEEN 2018 AND 2023, INCLUDING 38 PATIENTS WHO UNDERWENT REDO VATS ABOUT 22 MALES AND 16 FEMALES. VIDEO-ASSISTED THORACOSCOPIC SURGERY (VATS) LUNG RESECTION OPERATIONS (21 LOBECTOMIES, 3 SEGMENTECTOMIES 14 WEDGE RESECTIONS) WERE SAFELY PERFORMED IN PATIENTS WHO UNDERWENT PREVIOUS IPSILATERAL CHEST SURGERY (REDO). VARIOUS AEROSTATIC PRODUCTS (TACHOSIL, TAKEDA, JAPAN; PROGEL, BECTON DICKINSON, USA; NEOVEIL, GUNZE, USA) WERE UTILIZED BASED ON THE SURGEON¿S PREFERENCE. A SUBGROUP ANALYSIS WAS PROPOSED BASED ON THE MOST RELEVANT FACTORS TO CONSIDER WHEN PLANNING A REDO THORACIC PROCEDURE: CATEGORY OF PROCEDURE (LUNG RESECTION VS. OTHER), SURGICAL APPROACH (OPEN VS. VATS) AND TYPE OF LUNG RESECTION (ANATOMICAL VS. NON-ANATOMICAL) DURING THE INITIAL SURGERY; TYPE OF LUNG RESECTION (ANATOMICAL VS. NON-ANATOMICAL) DURING THE REDO PROCEDURE. POST OPERATIVE COMPLICATIONS INCLUDED: MEDIAN HOSPITAL LENGTH OF STAY WAS 5 (RANGE, 3¿24) DAYS, AND CHEST DRAINAGE LENGTH WAS 3 (RANGE, 1¿37) DAYS. COMPLICATIONS WERE OBSERVED IN SIXTEEN PATIENTS (42%), WITH THE MOST FREQUENT BEING PROLONGED AIR LEAK (>5 DAYS) IN 9 CASES (23.7%). PLEURAL EFFUSION DRAINAGE (1) PNEUMONIA (1), ATELECTASIS (2), ATRIAL FIBRILLATION (7), PULMONARY EMBOLISM (2) AND THE 30-DAY MORTALITY RATE WAS 0%. CONCLUSION REDO-VATS LUNG TUMOR RESECTION HAS BEEN DEMONSTRATED AS A SAFE AND FEASIBLE APPROACH WITH AN ACCEPTABLE CONVERSION RISK AND MORBIDITY. NOTE: THERE IS NO INFORMATION PROVIDED IN THE ARTICLE INDICATING THAT THE DEVICE CAUSED OR CONTRIBUTED TO THE POSTOPERATIVE PATIENT COMPLICATION(S). HOWEVER, AS POSTOPERATIVE COMPLICATIONS DID PRESENT AND SOME REQUIRING MEDICAL/SURGICAL INTERVENTION WE ARE REPORTING THIS AS A SERIOUS INJURY MDR.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2059841 PROGEL PLATINUM PLUERAL AIR LEAK SEALANT SEALANT, POLYMERIZING NBE NEOMEND INC -2953195 NA NI

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown Other| H